Tonix Pharmaceuticals Holding Corp. (TNXP)
5.67
-0.37
(-6.13%)
USD |
NASDAQ |
Oct 19, 14:46
Tonix Pharmaceuticals Cash from Operations (Annual) : -99.84M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -99.84M |
| December 31, 2024 | -60.92M |
| December 31, 2023 | -102.00M |
| December 31, 2022 | -98.05M |
| December 31, 2021 | -75.56M |
| December 31, 2020 | -48.57M |
| December 31, 2019 | -26.68M |
| December 31, 2018 | -23.97M |
| December 31, 2017 | -19.13M |
| December 31, 2016 | -37.32M |
| Date | Value |
|---|---|
| December 31, 2015 | -42.52M |
| December 31, 2014 | -22.84M |
| December 31, 2013 | -8.517M |
| December 31, 2012 | -5.713M |
| December 31, 2011 | -2.638M |
| December 31, 2010 | -1.233M |
| December 31, 2009 | -0.0279M |
| December 31, 2008 | -0.0236M |
| December 31, 2007 | -0.001M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Inovio Pharmaceuticals, Inc. | -88.63M |
| Nektar Therapeutics | -208.51M |
| Heron Therapeutics, Inc. | -27.59M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |